These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 31471103

  • 1. Novel lipid side chain modified exenatide analogs emerged prolonged glucoregulatory activity and potential body weight management properties.
    Li C, Cai X, Dai Y, Liu C, Bi X, Zhou J, Li Q, Sun L, Huang W, Hou Z, Qian H.
    Bioorg Med Chem; 2019 Oct 15; 27(20):115070. PubMed ID: 31471103
    [Abstract] [Full Text] [Related]

  • 2. Site-specific fatty chain-modified exenatide analogs with balanced glucoregulatory activity and prolonged in vivo activity.
    Sun L, Huang X, Han J, Cai X, Dai Y, Chu Y, Wang C, Huang W, Qian H.
    Biochem Pharmacol; 2016 Jun 15; 110-111():80-91. PubMed ID: 27155328
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Novel Site-Specific Fatty Chain-Modified GLP-1 Receptor Agonist with Potent Antidiabetic Effects.
    Zhong X, Chen Z, Chen Q, Zhao W, Chen Z.
    Molecules; 2019 Feb 21; 24(4):. PubMed ID: 30795583
    [Abstract] [Full Text] [Related]

  • 5. Novel glucagon- and OXM-based peptides acting through glucagon and GLP-1 receptors with body weight reduction and anti-diabetic properties.
    Cai X, Li C, Zhou J, Dai Y, Avraham Y, Sun L, Liu C, Tong J, Wang Y, Bi X, He L, Huang W, Qian H.
    Bioorg Chem; 2020 Jan 21; 95():103538. PubMed ID: 31901754
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The GLP-1 analogue exenatide improves hepatic and muscle insulin sensitivity in diabetic rats: tracer studies in the basal state and during hyperinsulinemic-euglycemic clamp.
    Wu H, Sui C, Xu H, Xia F, Zhai H, Zhang H, Weng P, Han B, Du S, Lu Y.
    J Diabetes Res; 2014 Jan 21; 2014():524517. PubMed ID: 25580440
    [Abstract] [Full Text] [Related]

  • 8. Design, screening and biological evaluation of novel fatty acid chain-modified oxyntomodulin-based derivatives with prolonged glucose-lowering ability and potent anti-obesity effects.
    Zhao L, Wang B, Wang L, Zhao X, Chen Z, Sun L.
    Org Biomol Chem; 2019 Sep 07; 17(33):7760-7771. PubMed ID: 31389463
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Characterisation and antidiabetic utility of a novel hybrid peptide, exendin-4/gastrin/xenin-8-Gln.
    Hasib A, Ng MT, Khan D, Gault VA, Flatt PR, Irwin N.
    Eur J Pharmacol; 2018 Sep 05; 834():126-135. PubMed ID: 30025814
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Lithocholic Acid-Based Peptide Delivery System for an Enhanced Pharmacological and Pharmacokinetic Profile of Xenopus GLP-1 Analogs.
    Han J, Chen X, Zhao L, Fu J, Sun L, Zhang Y, Zhou F, Fei Y.
    Mol Pharm; 2018 Jul 02; 15(7):2840-2856. PubMed ID: 29799205
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.